About Us
- Design and conduct clinical studies in breast and colorectal cancer to improve treatment and advance the standard of care.
- Learn about the heritage, expertise and vision that drives us forward every day.
  Learn More
- Meet the experts leading our organization in the pursuit of The Mission.
  Meet the Experts
- Read the latest announcements and press releases, or search our media library.
  Read the Latest
Our Network
- We leverage our expertise through close collaboration across our network to prove the efficacy of new cancer treatments.
- Thousands of sites facilitate trials by recruiting participants, administering treatments, and reporting results.
  View Sites
- Links to NCI National Clinical Trials Network along with Industry Partners and other Government Agencies.
  View Links
Patient Resources
Clinical Trials
Log In
- Visitors who have already been issued credentials must log in to access protected content.
  Log In
- Individuals working for sites that participate in NSABP clinical trials.
  Register Now
Support Our Mission

Clinical Trial Detailsnsabpwordpress2026-03-13T16:01:52-05:00

NSABP FC-13

Overview

Overview

NSABP FC-13

A Phase II Platform Study to Evaluate Treatment with Cemiplimab Monotherapy or Cemiplimab plus Fianlimab or Other Novel Combinations in Patients with Colorectal Cancer with Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)

Target Accrual: 57 patients

Status: Recruiting

ClinicialTrials.gov Identifier:

NSABP FC-13

Overview

Overview